Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunotherapy
New findings reported from G.R. Rossi and co-authors describe advances in immunotherapy
September 24th, 2008
According to a study from the United States, "Owing to the absence of alpha Gal epitopes in human cells and constant stimulation of the immune system by the symbiotic bacterial flora, humans develop high titers of natural antibodies against these epitopes. It has been demonstrated that syngeneic whole cell vaccines modified to express alpha Gal epitopes could be used to generate a potent anticancer vaccine." "In this study, we tested whether allogeneic whole cell cancer vaccines modified to express alpha Gal epitopes would be effective for the treatment of murine melanoma. The alpha(1,3) galactosyltransferase (alpha GT) knockout mice (H-2(b/b)) with preexisting...
Source: Vaccine Weekly (2008-09-24)
|
